C

Celgene

3004 employees

Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.

Investor insights

Sectors invested in

Biotechnology43
Health Care25
Therapeutics23
Medical19
Pharmaceutical12
Biopharma12
Health Diagnostics6
Genetics4
immuno-oncology4
Clinical Trials3
Immuno-Oncology2
Rare Genetic Diseases2
Biopharmaceuticals2
Cellular Metabolism2
Medical Device2
Medicinal Chemistry2
Large Molecule Drug Discovery2
Immuno-oncology2
Protein Therapeutics2
Cancer Risk Assessments2

Funding rounds participated in

$41M sweet spot round size

Most of their 53 investments are in rounds between $26M and $65M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
biopharma
Translation Medicine
Hematology
Oncology
Inflammation
R&D
Innovation
Immunology
Protein Homeostasis
Orphan diseases
Immunooncology
Epigenetics
Medical
Cancer

Date founded

1986

Investments made

C

Cyteir Therapeutics raised $40M on October 15, 2019

Investors: Novo Holdings, Venrock, Lightstone Ventures, Osage University Partners (OUP) and Celgene

A

Anokion raised $40M on September 11, 2019

Investors: Celgene

I

Immatics Biotechnologies raised $75M on September 5, 2019

Investors: Celgene

V

Vividion Therapeutics. Inc. raised $82M on April 30, 2019

Investors: Nextech Invest, Cardinal Partners (CP), Casdin Capital, LLC, Mirae Asset MAPS Global Investments Co., Ltd, Versant Ventures, ARCH Venture Partners and Celgene

A

Arrakis Therapeutics raised $75M on April 18, 2019

Investors: Omega Funds, Nextech Invest, WuXi AppTec, GV, venBio Partners, Osage University Partners (OUP) and Celgene

H

HiberCell raised $61M on February 7, 2019

Investors: Life Sciences Fund Amsterdam, 6 Dimensions Capital, ARCH Venture Partners, Magnetic Ventures, Hillhouse Capital Management and Celgene

B

Biond Biologics Ltd raised $17M on January 8, 2019

Investors: Celgene

E

Exscientia raised $26M on January 7, 2019

Investors: Evotec and Celgene

R

Ribon Therapeutics raised $65M on January 4, 2019

Investors: The Column Group, Osage University Partners (OUP), Takeda UK Limited and Celgene

U

Undisclosed raised $120M on January 2, 2019

Investors: 泰福资本 TF Capital, Boyu Capital, Qiming Venture Partners, 泰康集团, FountainVest Partners and Celgene

FAQ